Guido Groenen

1.0k total citations · 1 hit paper
20 papers, 760 citations indexed

About

Guido Groenen is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Guido Groenen has authored 20 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 10 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Guido Groenen's work include Leprosy Research and Treatment (13 papers), Mycobacterium research and diagnosis (9 papers) and Tuberculosis Research and Epidemiology (6 papers). Guido Groenen is often cited by papers focused on Leprosy Research and Treatment (13 papers), Mycobacterium research and diagnosis (9 papers) and Tuberculosis Research and Epidemiology (6 papers). Guido Groenen collaborates with scholars based in Belgium, Bangladesh and Ethiopia. Guido Groenen's co-authors include Ashraf Uddin Ahmed, Sean McAleer, Sue Roff, Mona Faisal Al-Qahtani, Ronald M. Harden, Vanessa Mathys, Paul Saunderson, Karine Soetaert, SR Pattyn and N. Saha and has published in prestigious journals such as PLoS ONE, Journal of Antimicrobial Chemotherapy and Medical Education.

In The Last Decade

Guido Groenen

20 papers receiving 711 citations

Hit Papers

Development and validation of the Dundee Ready Education ... 1997 2026 2006 2016 1997 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guido Groenen Belgium 11 370 266 205 145 142 20 760
François Cilliers South Africa 14 591 1.6× 306 1.2× 143 0.7× 193 1.3× 100 0.7× 32 986
Mary Horgan Ireland 17 291 0.8× 67 0.3× 169 0.8× 222 1.5× 181 1.3× 63 795
Grace Sweeney United Kingdom 17 99 0.3× 32 0.1× 39 0.2× 171 1.2× 30 0.2× 42 656
V. Fan Tait United States 3 460 1.2× 24 0.1× 248 1.2× 105 0.7× 163 1.1× 6 752
Steven D. Blatt United States 10 67 0.2× 12 0.0× 97 0.5× 63 0.4× 157 1.1× 30 654
Randa M. Youssef Egypt 14 185 0.5× 50 0.2× 36 0.2× 123 0.8× 48 0.3× 34 740
Frederick Edwards United States 10 175 0.5× 23 0.1× 97 0.5× 94 0.6× 87 0.6× 16 441
R M Fincher United States 12 310 0.8× 46 0.2× 41 0.2× 129 0.9× 43 0.3× 28 455
Ruth M. H. Peters Netherlands 17 65 0.2× 38 0.1× 459 2.2× 212 1.5× 112 0.8× 60 842
Teaniese L. Davis United States 11 63 0.2× 36 0.1× 114 0.6× 305 2.1× 41 0.3× 36 507

Countries citing papers authored by Guido Groenen

Since Specialization
Citations

This map shows the geographic impact of Guido Groenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Groenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Groenen more than expected).

Fields of papers citing papers by Guido Groenen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Groenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Groenen. The network helps show where Guido Groenen may publish in the future.

Co-authorship network of co-authors of Guido Groenen

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Groenen. A scholar is included among the top collaborators of Guido Groenen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Groenen. Guido Groenen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rie, Annelies Van, Darı́o Garcı́a de Viedma, Conor J. Meehan, et al.. (2021). Whole-genome sequencing for TB source investigations: principles of ethical precision public health. The International Journal of Tuberculosis and Lung Disease. 25(3). 222–227. 2 indexed citations
2.
Whitfield, Michael G., Robin M. Warren, Vanessa Mathys, et al.. (2018). The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis. Journal of Antimicrobial Chemotherapy. 73(10). 2667–2674. 16 indexed citations
3.
Soetaert, Karine, Guido Groenen, Maryse Wanlin, et al.. (2017). Molecular epidemiology of Mycobacterium tuberculosis complex in Brussels, 2010–2013. PLoS ONE. 12(2). e0172554–e0172554. 15 indexed citations
4.
Hasker, Epco, et al.. (2017). Leprosy on Anjouan (Comoros): persistent hyper-endemicity despite decades of solid control efforts. Leprosy Review. 88(3). 334–342. 10 indexed citations
5.
Mathys, Vanessa, et al.. (2014). False-positive rifampicin resistance on Xpert<SUP>®</SUP> MTB/RIF caused by a silent mutation in the <I>rpo</I>B gene. The International Journal of Tuberculosis and Lung Disease. 18(10). 1255–1257. 43 indexed citations
6.
Stoffels, Karolien, Caroline Allix‐Béguec, Guido Groenen, et al.. (2013). From Multidrug- to Extensively Drug-Resistant Tuberculosis: Upward Trends as Seen from a 15-Year Nationwide Study. PLoS ONE. 8(5). e63128–e63128. 22 indexed citations
7.
Groenen, Guido. (2002). Trends in prevalence and case finding in the ALERT leprosy control programme, 1979–1999. Leprosy Review. 73(1). 29–40. 9 indexed citations
8.
Saunderson, Paul & Guido Groenen. (2000). Which physical signs help most in the diagnosis of leprosy? A proposal based on experience in the AMFES project, ALERT, Ethiopia. Leprosy Review. 71(1). 34–42. 19 indexed citations
9.
McAleer, Sean, Sue Roff, Ronald M. Harden, et al.. (1998). The Medical Education Environment Measure: a diagnostic tool. Medical Education. 32(2). 217–217. 12 indexed citations
10.
Roff, Sue, Sean McAleer, Ronald M. Harden, et al.. (1997). Development and validation of the Dundee Ready Education Environment Measure (DREEM). Medical Teacher. 19(4). 295–299. 530 indexed citations breakdown →
11.
Groenen, Guido, et al.. (1995). Classification of leprosy cases under field conditions in Bangladesh. II. Reliability of clinical criteria. Leprosy Review. 66(2). 134–43. 10 indexed citations
12.
Groenen, Guido, et al.. (1995). Classification of leprosy cases under field conditions in Bangladesh. I. Usefulness of skin-smear examinations. Leprosy Review. 66(2). 126–33. 13 indexed citations
13.
Pattyn, S. R., et al.. (1992). Treatment of multibacillary leprosy with a regimen of 13 weeks duration. Leprosy Review. 63(1). 41–6. 3 indexed citations
15.
Groenen, Guido, et al.. (1990). A longitudinal study of the incidence of leprosy in a hyperendemic area in Zaïre, with special reference to PGL-antibody results.. 58(4). 641–650. 6 indexed citations
16.
Groenen, Guido, et al.. (1990). A longitudinal study of the incidence of leprosy in a hyperendemic area in Zaire, with special reference to PGL-antibody results. The Yalisombo Study Group.. PubMed. 58(4). 641–50. 12 indexed citations
18.
Pattyn, S. R., et al.. (1988). The incubation time of relapses after treatment of multibacillary leprosy with rifampicin containing regimens. European Journal of Epidemiology. 4(2). 231–234. 8 indexed citations
20.
Groenen, Guido, et al.. (1986). Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.. PubMed. 54(2). 236–44. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026